These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 25097219
1. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes. Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J. Circ Res; 2014 Sep 26; 115(8):721-9. PubMed ID: 25097219 [Abstract] [Full Text] [Related]
2. Ube2v1 Positively Regulates Protein Aggregation by Modulating Ubiquitin Proteasome System Performance Partially Through K63 Ubiquitination. Xu N, Gulick J, Osinska H, Yu Y, McLendon PM, Shay-Winkler K, Robbins J, Yutzey KE. Circ Res; 2020 Mar 27; 126(7):907-922. PubMed ID: 32081062 [Abstract] [Full Text] [Related]
3. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. Gupta MK, McLendon PM, Gulick J, James J, Khalili K, Robbins J. Circ Res; 2016 Jun 10; 118(12):1894-905. PubMed ID: 27142163 [Abstract] [Full Text] [Related]
4. Inhibition of Mutant αB Crystallin-Induced Protein Aggregation by a Molecular Tweezer. Xu N, Bitan G, Schrader T, Klärner FG, Osinska H, Robbins J. J Am Heart Assoc; 2017 Aug 08; 6(8):. PubMed ID: 28862927 [Abstract] [Full Text] [Related]
5. COP9 signalosome controls the degradation of cytosolic misfolded proteins and protects against cardiac proteotoxicity. Su H, Li J, Zhang H, Ma W, Wei N, Liu J, Wang X. Circ Res; 2015 Nov 06; 117(11):956-66. PubMed ID: 26383969 [Abstract] [Full Text] [Related]
10. Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways. Zhang H, Rajasekaran NS, Orosz A, Xiao X, Rechsteiner M, Benjamin IJ. J Mol Cell Cardiol; 2010 Dec 03; 49(6):918-30. PubMed ID: 20863832 [Abstract] [Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways. Ahner A, Gong X, Frizzell RA. FEBS J; 2013 Sep 03; 280(18):4430-8. PubMed ID: 23809253 [Abstract] [Full Text] [Related]
12. Making the connections: Autophagy and post-translational modifications in cardiomyocytes. Gupta MK, Robbins J. Autophagy; 2016 Nov 03; 12(11):2252-2253. PubMed ID: 27573291 [Abstract] [Full Text] [Related]
14. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. Liu J, Tang M, Mestril R, Wang X. J Mol Cell Cardiol; 2006 Apr 03; 40(4):451-4. PubMed ID: 16481005 [Abstract] [Full Text] [Related]
17. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, Li J, Li F, Gerdes AM, Wawrousek EF, Wang X. Circ Res; 2005 Nov 11; 97(10):1018-26. PubMed ID: 16210548 [Abstract] [Full Text] [Related]
18. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Dong X, Liu J, Zheng H, Glasford JW, Huang W, Chen QH, Harden NR, Li F, Gerdes AM, Wang X. Am J Physiol Heart Circ Physiol; 2004 Sep 11; 287(3):H1417-25. PubMed ID: 15105173 [Abstract] [Full Text] [Related]
19. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. He X, Lai Q, Chen C, Li N, Sun F, Huang W, Zhang S, Yu Q, Yang P, Xiong F, Chen Z, Gong Q, Ren B, Weng J, Eizirik DL, Zhou Z, Wang CY. Diabetologia; 2018 Apr 11; 61(4):881-895. PubMed ID: 29299635 [Abstract] [Full Text] [Related]
20. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A. J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]